Biophyle Unveils Groundbreaking Accelerator Program for Clinical-Stage Biotech Innovations and Local Research Training

In a major boost to healthcare innovation, SymBiosis and HealthTech Arkansas have announced the launch of the biophyle Trial Accelerator, a pioneering initiative aimed at bridging the gap between cutting-edge clinical-stage biotherapeutics and Arkansas’ healthcare ecosystem. This strategic program is designed to catalyze the commercialization of novel treatments by connecting biotherapeutic innovations with clinical trial…

Read More

Icebreaker Raises $5M Seed Round to Redefine Professional Networking with Cryptographic Technology

Icebreaker, a pioneering force in the realm of professional networking, has announced the successful completion of a $5 million seed funding round, spearheaded by CoinFund. This impressive round also saw participation from Accomplice, Anagram, Legion Capital, and a distinguished group of over 30 founder angels. The newly secured funds are set to propel Icebreaker’s ambitious…

Read More

Rhombus Secures $45M Series C Funding to Enhance Global Security Solutions

Rhombus, a trailblazer in cloud-managed physical security solutions, has successfully completed a $45 million Series C funding round. The investment was spearheaded by NightDragon, with participation from Bluestone Equity Partners, alongside existing supporters Caden Capital, Cota Capital, Tru Arrow Partners, and Uncorrelated Ventures. This latest infusion of capital brings Rhombus’ total funding to over $90…

Read More

Gigpro Secures $16M Series A Financing to Revolutionize Hospitality Labor Market

Gigpro, a trailblazer in on-demand labor solutions for the hospitality sector, has successfully closed a $16 million Series A funding round. This substantial investment was spearheaded by Foundry, with notable participation from Stage 1 Ventures, Stage 2 Capital, and Detroit Venture Partners. The new capital will catalyze Gigpro’s mission to reshape the gig economy and…

Read More

Noze Receives Historic $5M Investment from Bill & Melinda Gates Foundation to Advance Breath-Based Diagnostics

Noze, the innovative leader in breath-based diagnostic technology, has secured a transformative $5 million equity investment from the Bill & Melinda Gates Foundation. This groundbreaking funding is notable as it represents the Gates Foundation’s inaugural equity investment in a Canadian enterprise. The new investment, part of an extended funding round, builds on previous grants totaling…

Read More

Perchwell Secures $25 Million Series B to Revolutionize Real Estate Technology

Perchwell, a trailblazer in modernizing real estate data and workflow management, has successfully closed a $25 million Series B funding round. The investment round was spearheaded by Lux Capital and includes contributions from prominent real estate and financial entities such as Starwood Capital Group, Flex Capital, Stellar MLS, REcolorado MLS, and California Regional MLS (CRMLS)….

Read More

DecoverAI Secures $2M Seed Funding to Transform Legal Tech with Advanced AI Solutions

DecoverAI, a trailblazer in legal technology, has successfully closed a $2 million seed funding round, led by Leo Capital and supported by additional prominent investors. This infusion of capital marks a significant leap forward in DecoverAI’s mission to revolutionize the legal field with its innovative “Legal Brain” and Generative Defense technologies. Founded in 2024, DecoverAI…

Read More

OpusFlow Secures €1.7 Million from Peak to Propel International Expansion and Innovate ERP Solutions for Sustainable Installers

OpusFlow, the leading provider of all-in-one ERP solutions tailored for sustainable installation companies, has successfully raised €1.7 million in a funding round led by Peak, a renowned B2B SaaS investor. This investment will fuel OpusFlow’s mission to enhance its cutting-edge product and extend its reach across Europe, supporting installers of solar panels, heat pumps, home…

Read More

Pinetree Therapeutics Raises $17M to Propel Breakthrough Cancer Therapies with Innovative Protein Degradation Platform

Pinetree Therapeutics, Inc., a trailblazer in targeted protein degradation (TPD) technology, has successfully closed a Series A funding round, raising $17 million to advance its AbReptor™ platform. This investment round was co-led by STIC Investments and DSC Investment, with new participation from Atinum Investment, Quantum FA, and S&S Investment, alongside existing backers DSC Investment, Schmidt,…

Read More